165 related articles for article (PubMed ID: 20849600)
1. Human vascular adhesion proteın-1 (VAP-1): serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease.
Kemik O; Sümer A; Kemik AS; Itik V; Dulger AC; Purisa S; Tuzun S
World J Surg Oncol; 2010 Sep; 8():83. PubMed ID: 20849600
[TBL] [Abstract][Full Text] [Related]
2. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
[TBL] [Abstract][Full Text] [Related]
3. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease.
Kurkijärvi R; Yegutkin GG; Gunson BK; Jalkanen S; Salmi M; Adams DH
Gastroenterology; 2000 Oct; 119(4):1096-103. PubMed ID: 11040196
[TBL] [Abstract][Full Text] [Related]
4. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M
J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971
[TBL] [Abstract][Full Text] [Related]
5. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
[TBL] [Abstract][Full Text] [Related]
6. Circulating vascular adhesion protein-1(VAP-1): a possible biomarker for liver fibrosis associated with chronic hepatitis B and C.
Öksüz Z; Üçbilek E; Serin MS; Yaraş S; Temel GO; Sezgin O
Braz J Microbiol; 2020 Dec; 51(4):1757-1763. PubMed ID: 32959205
[TBL] [Abstract][Full Text] [Related]
7. Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis.
Weston CJ; Shepherd EL; Claridge LC; Rantakari P; Curbishley SM; Tomlinson JW; Hubscher SG; Reynolds GM; Aalto K; Anstee QM; Jalkanen S; Salmi M; Smith DJ; Day CP; Adams DH
J Clin Invest; 2015 Feb; 125(2):501-20. PubMed ID: 25562318
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M
J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684
[TBL] [Abstract][Full Text] [Related]
9. Vascular Adhesion Protein-1 (VAP-1) as Predictor of Radiographic Severity in Symptomatic Knee Osteoarthritis in the New York University Cohort.
Bournazou E; Samuels J; Zhou H; Krasnokutsky S; Patel J; Han T; Bencardino J; Rybak L; Abramson SB; Junker U; Brown KS; Attur M
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146362
[TBL] [Abstract][Full Text] [Related]
10. A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease.
Gray J; Chattopadhyay D; Beale GS; Patman GL; Miele L; King BP; Stewart S; Hudson M; Day CP; Manas DM; Reeves HL
BMC Cancer; 2009 Aug; 9():271. PubMed ID: 19656391
[TBL] [Abstract][Full Text] [Related]
11. Circulating soluble vascular adhesion protein 1 in patients with inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Vardas E; Dimoulios P; Roussomoustakaki M; Maniatis AN; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):405-8. PubMed ID: 11943954
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum and tissue levels of VAP-1 in colorectal cancer.
Ward ST; Weston CJ; Shepherd EL; Hejmadi R; Ismail T; Adams DH
BMC Cancer; 2016 Feb; 16():154. PubMed ID: 26912327
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum soluble vascular adhesion protein-1 level and gastric cancer prognosis.
Kaplan MA; Kucukoner M; Inal A; Urakci Z; Evliyaoglu O; Firat U; Kaya M; Isikdogan A
Oncol Res Treat; 2014; 37(6):340-4. PubMed ID: 24903765
[TBL] [Abstract][Full Text] [Related]
14. Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma.
Koyama N; Yamazaki T; Kanetsuki Y; Hirota J; Asai T; Mitsumoto Y; Mizuno M; Shima T; Kanbara Y; Arai S; Miyazaki T; Okanoue T
J Gastroenterol; 2018 Jun; 53(6):770-779. PubMed ID: 29086016
[TBL] [Abstract][Full Text] [Related]
15. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
[TBL] [Abstract][Full Text] [Related]
16. Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients.
Madej A; Reich A; Orda A; Szepietowski JC
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):72-8. PubMed ID: 17207171
[TBL] [Abstract][Full Text] [Related]
17. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes.
Yoshikawa N; Noda K; Shinoda H; Uchida A; Ozawa Y; Tsubota K; Mashima Y; Ishida S
J Diabetes Complications; 2013; 27(2):162-6. PubMed ID: 23062326
[TBL] [Abstract][Full Text] [Related]
18. Serum level of soluble vascular cell adhesion molecule in patients with hepatocellular carcinoma and its association with severity of liver disease.
Diaz-Sanchez A; Matilla A; Nuñez O; Rincon D; Lorente R; Lo Iacono O; Merino B; Hernando A; Campos R; Clemente G; Bañares R
Ann Hepatol; 2013; 12(2):236-47. PubMed ID: 23396735
[TBL] [Abstract][Full Text] [Related]
19. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
Ataseven A; Kesli R
G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
[TBL] [Abstract][Full Text] [Related]
20. Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non-B or Non-C Hepatocellular Carcinoma.
Kan H; Yamagishi S; Ojima A; Fukami K; Ueda S; Takeuchi M; Hyogo H; Aikata H; Chayama K
J Clin Lab Anal; 2015 Nov; 29(6):480-4. PubMed ID: 25252033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
